241 related articles for article (PubMed ID: 22180281)
21. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.
Gerber T; Schomerus H
Drugs; 2000 Dec; 60(6):1353-70. PubMed ID: 11152016
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of rifaximin in management of hepatic encephalopathy.
Wahib AA; El-Deen Salem MN; Ahmed MA; El-Dessouky YM; El-Tiby DM; El-Mola K; El-Sayed AM
J Egypt Soc Parasitol; 2014 Dec; 44(3):677-85. PubMed ID: 25643509
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
24. Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.
Williams R; Bass N
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S10-8. PubMed ID: 15976747
[TBL] [Abstract][Full Text] [Related]
25. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial.
Miglio F; Valpiani D; Rossellini SR; Ferrieri A
Curr Med Res Opin; 1997; 13(10):593-601. PubMed ID: 9327194
[TBL] [Abstract][Full Text] [Related]
26. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
Zhu GQ; Shi KQ; Huang S; Wang LR; Lin YQ; Huang GQ; Chen YP; Braddock M; Zheng MH
Aliment Pharmacol Ther; 2015 Apr; 41(7):624-35. PubMed ID: 25684317
[TBL] [Abstract][Full Text] [Related]
27. Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.
Eltawil KM; Laryea M; Peltekian K; Molinari M
World J Gastroenterol; 2012 Feb; 18(8):767-77. PubMed ID: 22371636
[TBL] [Abstract][Full Text] [Related]
28. Rifaximin for the treatment of hepatic encephalopathy.
Lawrence KR; Klee JA
Pharmacotherapy; 2008 Aug; 28(8):1019-32. PubMed ID: 18657018
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy for the treatment and prevention of hepatic encephalopathy.
Mohammad RA; Regal RE; Alaniz C
Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
[TBL] [Abstract][Full Text] [Related]
30. Hepatic encephalopathy due to liver cirrhosis.
Ellul MA; Gholkar SA; Cross TJ
BMJ; 2015 Aug; 351():h4187. PubMed ID: 26265724
[No Abstract] [Full Text] [Related]
31. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Pirotte J; Guffens JM; Devos J
Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
[No Abstract] [Full Text] [Related]
32. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
Huang E; Esrailian E; Spiegel BM
Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
[TBL] [Abstract][Full Text] [Related]
33. Hepatic encephalopathy syndromes.
Tandon BN
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S4-6. PubMed ID: 15025244
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure.
Kodali S; McGuire BM
Clin Liver Dis; 2015 Aug; 19(3):565-76. PubMed ID: 26195209
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Overt Hepatic Encephalopathy.
Sussman NL
Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
[TBL] [Abstract][Full Text] [Related]
36. Hepatic encephalopathy.
Córdoba J; Mínguez B
Semin Liver Dis; 2008 Feb; 28(1):70-80. PubMed ID: 18293278
[TBL] [Abstract][Full Text] [Related]
37. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
[TBL] [Abstract][Full Text] [Related]
38. Hepatic encephalopathy: pathophysiology and advances in therapy.
Av SP
Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
[TBL] [Abstract][Full Text] [Related]
39. Hepatic encephalopathy.
Khungar V; Poordad F
Clin Liver Dis; 2012 May; 16(2):301-20. PubMed ID: 22541700
[TBL] [Abstract][Full Text] [Related]
40. Durability of rifaximin response in hepatic encephalopathy.
Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
